These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15935736)

  • 1. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules.
    Orive G; De Castro M; Ponce S; Hernández RM; Gascón AR; Bosch M; Alberch J; Pedraz JL
    Mol Ther; 2005 Aug; 12(2):283-9. PubMed ID: 15935736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules.
    Murua A; de Castro M; Orive G; Hernandez RM; Pedraz JL
    Biomacromolecules; 2007 Nov; 8(11):3302-7. PubMed ID: 17941669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression.
    Murua A; Orive G; Hernández RM; Pedraz JL
    J Control Release; 2009 Aug; 137(3):174-8. PubMed ID: 19376171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts.
    Murua A; Orive G; Hernández RM; Pedraz JL
    Biomaterials; 2009 Jul; 30(20):3495-501. PubMed ID: 19327822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a composite drug delivery system to prolong functionality of cell-based scaffolds.
    Murua A; Herran E; Orive G; Igartua M; Blanco FJ; Pedraz JL; Hernández RM
    Int J Pharm; 2011 Apr; 407(1-2):142-50. PubMed ID: 21094235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.
    De Castro M; Orive G; Hernández RM; Bartkowiak A; Brylak W; Pedraz JL
    J Biomed Mater Res A; 2009 Dec; 91(4):1119-30. PubMed ID: 19145624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules.
    Ponce S; Orive G; Hernández RM; Gascón AR; Canals JM; Muñoz MT; Pedraz JL
    J Control Release; 2006 Nov; 116(1):28-34. PubMed ID: 17081643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells.
    Acarregui A; Pedraz JL; Blanco FJ; Hernández RM; Orive G
    Biomacromolecules; 2013 Feb; 14(2):322-30. PubMed ID: 23231457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
    Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
    Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of the initial host immuno-inflammatory response determines the long-term survival of encapsulated myoblasts genetically engineered for erythropoietin delivery.
    Schneider BL; Schwenter F; Pralong WF; Aebischer P
    Mol Ther; 2003 Apr; 7(4):506-14. PubMed ID: 12727114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.
    Güttinger M; Padrun V; Pralong WF; Boison D
    Exp Neurol; 2005 May; 193(1):53-64. PubMed ID: 15817264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression.
    Peduto G; Rinsch C; Schneider BL; Rolland E; Aebischer P
    Transplantation; 2000 Jul; 70(1):78-85. PubMed ID: 10919579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
    Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
    Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia.
    Rinsch C; Dupraz P; Schneider BL; Déglon N; Maxwell PH; Ratcliffe PJ; Aebischer P
    Kidney Int; 2002 Oct; 62(4):1395-401. PubMed ID: 12234311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactive cell-hydrogel microcapsules for cell-based drug delivery.
    Orive G; De Castro M; Kong HJ; Hernández RM; Ponce S; Mooney DJ; Pedraz JL
    J Control Release; 2009 May; 135(3):203-10. PubMed ID: 19344677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
    Eliopoulos N; Gagnon RF; Francois M; Galipeau J
    J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small agarose microcapsules with cell-enclosing hollow core for cell therapy: transplantation of Ifosfamide-activating cells to the mice with preestablished subcutaneous tumor.
    Sakai S; Hashimoto I; Tanaka S; Salmons B; Kawakami K
    Cell Transplant; 2009; 18(8):933-9. PubMed ID: 19500478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.